Group 1 | Group 2 | |
---|---|---|
(n = 322) | (n = 125) | |
Age (years) | 38.6 ± 5.4 | 38.9 ± 5.4 |
BMI** (kg/m2) | 24.0 ± 4.9 | 24.1 ± 4.6 |
DHEA (ng/dL) | 469.2 ± 289.8 | 467.9 ± 308.9 |
DHEAS (μg/dL) | 253.5 ± 189.0 | 371.6 ± 233.4 |
Total testosterone (ng/dL) | 26.0 ± 13.7 | 33.7 ± 23.5 |
Free testosterone (pg/mL) | 2.0 ± 1.5 | 2.6 ± 1.8 |
TSH (μIU/mL) | 1.9 ± 1.2 | 1.9 ± 1.0 |
Thyroid antibodies | 22.0% | 16.0% |
Anti-adrenal antibodies | 0.3% | 0% |
Anti-ovarian antibodies | 9.3% | 6.4% |
Antinuclear antibodies (ANA) | 13.0% | 7.2% |
Antiphopholipid antibodies (APA) | 14.6% | 14.4% |
Gammopathy | 32.0% | 36.0% |
Immune system activation*** | 59.0% | 59.2% |